ArticleEmerging microbes & infections2023
Epidemiological characteristics and molecular features of carbapenem-resistant
Article in Emerging microbes & infections, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 23 citations in OpenAlex.
- Can we escape from top-priority ESKAPE pathogens?Emerging microbes & infections · 2026Review
- Genomic characterization ofMicrobiology spectrum · 2026Article
- Characterization of IMI-4 carbapenemase-producing Enterobacter sp. isolated from humans and a companion animal in French Indian Ocean territories.The Journal of antimicrobial chemotherapy · 2026Article
- Genome sequence of a lytic phage phi1_171026 targeting carbapenem-resistantMicrobiology resource announcements · 2026Article
- Clinical and molecular characterization of NDM-9 and NDM-13 producing multidrug-resistant Escherichia coli strains in China.BMC microbiology · 2026Article
- The clinical impact and dissemination of carbapenemase-producingMicrobiology spectrum · 2025Article
- Article
- Plasmid genomic epidemiology ofMicrobial genomics · 2025Article
- Infections caused by clonal spread of metallo-beta-lactamase-producingMicrobiology spectrum · 2025Article
- Optimizing phage therapy for carbapenem-resistantAntimicrobial agents and chemotherapy · 2025Article
- Loop-Mediated Isothermal Amplification (LAMP) for Rapid and Sensitive Detection of Carbapenemase Genes in CRE: A Diagnostic Validation Study.Infection and drug resistance · 2025Article
- Emergence of KPC-2 and NDM-13-coproducing carbapenem-resistant hypervirulentFrontiers in microbiology · 2025Article
- Genomic characteristics of ST6115 carbapenem-resistantFrontiers in microbiology · 2025Article
- Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance inFrontiers in cellular and infection microbiology · 2025Article
- Acquisition and Transmission ofInfection and drug resistance · 2025Article
- ESKAPE in China: epidemiology and characteristics of antibiotic resistance.Emerging microbes & infections · 2024Review
- First documentation of a clinical multidrug-resistant Enterobacter chuandaensis ST2493 isolate co-harboring blaScientific reports · 2024Article
- Genomic Analysis ofAntibiotics (Basel, Switzerland) · 2024Article
- Genome sequence-based species classification ofMicrobiology spectrum · 2024Article
- Carbapenem-ResistantInfection and drug resistance · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 9 institutions in 2 countries.
Funding
Abstract
Epidemiological characteristics and molecular features of carbapenem-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.